LazyNews Desk
Artificial Intelligence
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss - CNBC
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Login
Sign in to comment with your preferred method.
Or register with email